Cencora Inc (COR) FY2025Q4 Earning Prediction

11/05 05:00:00

Pre-Market

Cencora Inc (COR) is set to release its FY2025Q4 earnings performance on 11/05 05:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 83.39B and an earnings per share (EPS) of 3.79 for the FY2025Q4. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!

Estimate

Actual

Surprise

RevenueBEAT

83.39B

83.73B

+0.40%

EPSBEAT

3.79

3.84

+1.32%

AI Summary

Report

Attend Webcast

AI Earnings Prediction

Prediction for FY2025Q4

Earnings Date: Nov 5, 2025

The forecast predicts a 'Beat' due to strong growth in U.S. Healthcare and effective share buybacks, despite some regulatory uncertainties.

Beat

Last 0 quarters:

4 beats1 misses

Scenario Analysis

The AI analyzes the probability of each scenario occurring and identifies the triggering conditions.

Scenario

Prob.

Stock Reaction

Trigger Condition

Strong Beat

20%

+3-5%

Revenue >$84B + EPS >$3.90; guidance upgrade on RCA synergies.

Beat

50%

+1-3%

Revenue $83.4-84B + EPS $3.80-3.90; stable 2026 outlook.

Neutral

20%

Flat

Revenue/EPS in line; vague commentary on pricing probe.

Miss

-2-4%

International margins drag operating income below consensus.

Strong Miss

-5-7%

U.S. growth stalls + regulatory risks escalate.

Unlock Free Scenario Probability

Key Indicators Forecast

The AI provides itemized forecasts for key indicators, potentially including revenue, EPS, gross margin, and free cash flow.

Revenue

EPS

Currency:

No data

Actual

Estimate

Metric

Prediction

Justification

Revenue

Beat

Strong U.S. Healthcare growth (+ specialty/European tailwinds) outweighs international margin softness.

EPS

Beat

Share buybacks and operating income growth offset higher interest expenses.

Unlock Free Key Indicators Forecast

Prediction Logic & Rational

Logic & Justification

U.S. Healthcare Solutions Revenue: Positive momentum from specialty drug distribution and European market strength (per Mizuho/UBS) supports revenue growth, likely exceeding conservative estimates.
RCA Acquisition Profitability: Analysts highlight "earnings growth acceleration" in U.S. Healthcare (Wells Fargo), implying RCA synergies are materializing, boosting gross margins.
Share Repurchases: Active buybacks (implied by reduced share count) directly enhance EPS, offsetting potential net interest expense headwinds.
Risks: Trump’s drug-pricing probe creates regulatory uncertainty but lacks immediate financial impact for Q

Leadership transition (Durcan as Chairman) signals stability, not disruption.

Prediction Logic & Rational

Tactical Strategy Recommendations

Trading Strategy

Options: Long November $345 calls (benefit from post-earnings rally) or bull put spreads (e.g., $330/$335) to capitalize on high implied volatility.
Equity: Hold core position but trim exposure into strength (22% YTD run-up limits upside).
Hedge: Short-term puts as insurance against drug-pricing rhetoric.

Rationale: High expectations (22% stock outperformance) require a "Beat" to sustain momentum. Fact data leans positive, but regulatory risks cap "Strong Beat" odds.

Tactical Strategy Recommendations

Earnings Surprise Analysis

The chart displays the extent of earnings surprises and corresponding stock price movements for each earnings event.

Revenue

EPS

COR Transcript

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Neutral12-2

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Neutral12-2

Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript

Positive11-5

The earnings call highlights strong financial performance with a 9% revenue growth and 16% operating income increase. The raised EPS guidance and strategic focus on specialty growth and MSO platforms are positive indicators. The Q&A session reveals confidence in sustainable growth and strategic investments, despite some uncertainties in asset sales. The dividend increase and share repurchases further enhance shareholder value. Overall, the company's optimistic outlook, strategic execution, and financial metrics suggest a positive stock price movement over the next two weeks.

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Neutral9-10

COR Slides

Cencora Q2 2025 slides: adjusted EPS jumps 16.3%, guidance raised

2025-05-07

Cencora Q3 2025 slides: U.S. segment drives 19.8% EPS growth, guidance raised

2025-08-06

COR Report

Frequently Asked Questions

What is the Cencora Inc FY2025Q4 Earnings Release Date and Time?

Cencora Inc (COR) is scheduled to release its FY2025Q4 earnings report onNov 5, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.

What Are the Consensus Forecasts for Cencora Inc FY2025Q4 Revenue and EPS?

Analysts' consensus predicts 83.39B in revenue and an EPS of 3.79 for Cencora Inc's FY2025Q4.

What Does Intellectia's AI Predict for Cencora Inc FY2025Q4 Earnings?

Intellectia's exclusive AI algorithms forecast a Beat forCencora Inc's FY2025Q4 earnings, with a prediction date of Nov 5, 2025. Cencora Inc The forecast predicts a 'Beat' due to strong growth in U.S. Healthcare and effective share buybacks, despite some regulatory uncertainties.

How Can I Use This Earnings Prediction to Trade COR Stock?

Leverage Intellectia's AI forecast to position trades ahead of theNov 5, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.

How Accurate Is Intellectia's AI for Earnings Predictions Like Cencora Inc FY2025Q4?

Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.

How does AI Earnings Prediction generate its forecasts?

AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!

When are the predictions available, and how often are they updated?

Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.

Can I use AI Earnings Prediction for all types of stocks?

Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!